Activity/NN
of/IN
the/DT
kappa/NN
B/NN
enhancer/NN
of/IN
the/DT
interleukin-2/NN
receptor/NN
alpha/NN
chain/NN
in/IN
somatic/JJ
cell/NN
hybrids/NNS
is/VBZ
accompanied/VBN
by/IN
the/DT
nuclear/JJ
localization/NN
of/IN
NF-kappa/NN
B/NN
./.

The/DT
two/CD
nuclear/JJ
proteins/NNS
NF-kappa/NN
B/NN
(/(
consisting/VBG
of/IN
subunits/NNS
p50/NN
an/DT
dp65/NN
)/)
and/CC
the/DT
DNA-binding/JJ
subunit/NN
of/IN
NF-kappa/NN
B/NN
(/(
p50/NN
)/)
by/IN
itself/PRP
,/,
also/RB
called/VBN
KBF1/NN
,/,
are/VBP
constitutively/RB
expressed/VBN
and/CC
localized/JJ
in/IN
the/DT
nucleus/NN
of/IN
the/DT
human/JJ
T-cell/NN
line/NN
IARC/NN
301.5/CD
./.
=====
In/IN
order/NN
to/TO
define/VB
the/DT
roles/NNS
of/IN
these/DT
two/CD
factors/NNS
,/,
which/WDT
bind/VBP
to/TO
the/DT
same/JJ
kappa/NN
B/NN
enhancers/NNS
,/,
in/IN
transcription/NN
activation/NN
we/PRP
have/VBP
prepared/VBN
somatic/JJ
cell/NN
hybrids/NNS
between/IN
IARC/NN
301.5/CD
and/CC
a/DT
murine/JJ
myeloma/NN
./.
=====
Most/JJS
hybrids/NNS
express/VBP
both/CC
KBF1/NN
and/CC
NF-kappa/NN
B/NN
in/IN
their/PRP$
nuclei/NNS
,/,
but/CC
one/CD
hybrid/NN
expresses/VBZ
only/RB
KBF1/NN
./.
=====
The/DT
kappa/NN
B/NN
enhancer/NN
of/IN
the/DT
gene/NN
encoding/VBG
the/DT
interleukin-2/NN
(/(
IL-2/NN
)/)
receptor/NN
alpha/NN
chain/NN
(/(
IL-2R/NN
alpha/NN
)/)
is/VBZ
functional/JJ
only/RB
in/IN
the/DT
hybrids/NNS
expressing/VBG
nuclear/JJ
NF-kappa/NN
B/NN
./.
=====
These/DT
findings/NNS
show/VBP
that/IN
nuclear/JJ
NF-kappa/NN
B/NN
is/VBZ
necessary/JJ
to/TO
activate/VB
the/DT
kappa/NN
B/NN
enhancer/NN
,/,
while/IN
KBF1/NN
by/IN
itself/PRP
is/VBZ
not/RB
sufficient/JJ
./.
=====
We/PRP
propose/VBP
that/IN
KBF1/NN
is/VBZ
a/DT
competitive/JJ
inhibitor/NN
of/IN
NF-kappa/NN
B/NN
and/CC
discuss/VB
how/WRB
these/DT
factors/NNS
may/MD
be/VB
involved/VBN
in/IN
the/DT
transient/JJ
expression/NN
of/IN
IL-2/NN
and/CC
IL-2/NN
alpha/NN
genes/NNS
during/IN
the/DT
immune/JJ
response/NN
./.